 |
|
|
| |
Short duration treatment with AL-335 and odalasvir (ODV), with or without simeprevir (SMV), in treatment naïve patients with hepatitis C virus (HCV) genotype (GT) 1 infection
|
| |
| |
Reported by Jules Levin
EASL Special Conference Paris, France Sept 23 2016
Ed Gane1, Matthew W. McClure2, David Apelian3, Chris Westland2, Thomas N. Kakuda2, Sushmita Chanda2, Lawrence Blatt2, Leo Beigelman2, David B. Smith2, John Fry2 1. New Zealand Liver Transplant Unit, Auckland City Hospital, New Zealand; 2. Alios BioPharma Inc, South San Francisco, CA, United States; 3. Achillion Pharmaceuticals, New Haven, CT, United States
|
| |
|
|
|
|
|
